Christopher Mugnaini, None;
Joseph Abraham, None;
Charles C. Wykoff, Adverum (F), Alimera Sciences (C), Allegran (F), Allegro (C), Allergan (C), Alynylam (C), Apellis (C), Apellis (F), Bayer (C), Clearside (F), Clearside (C), D.O.R.C. (C), EyePoint (F), EyePoint (C), Genentech/Roche (F), Genentech/Roche (C), Neurotech (F), Novartis (F), Novartis (C), Regeneron (F), Regeneron (S), Regeneron (C), Regenxbio (F), Samsung (F), Santen (F);
Leina Lunasco, None;
David Brown, Adverum (F), Allegran (F), Allergan (C), Apellis (F), Apellis (C), Bayer (C), Biotime (C), Chengdu Kanghong Biotechnology (C), Clearside (F), Gemini (C), Genentech/Roche (F), Heidelberg (C), Novartis (F), Novartis (C), OHR (C), Opthea (F), Optos (C), Regeneron (F), Regeneron (C), Regenxbio (F), Regenxbio (C), Samsung (F), Santen (F), Senju (C), Zeiss (C);
sruthi arepalli, None;
Sunil Srivastava, Allergan (F), Bausch and Lomb (C), Gilead (F), Leica (P), Regeneron (F), Santen (C);
Alison Martin, None;
Katie Gregory, None;
Jamie Reese, None;
Justis Ehlers, Aerpio (F), Alcon (F), Allergan (F), Allergro (C), Genentech/Roche (F), Leica (C), Leica (P), Novartis (F), Regeneron (F), Santen (C), Thrombogenics/Oxurion (F), Zeiss (C)